Delphi advised Momentum Group on the deal. Momentum Group completed the acquisition of 70 per cent of the shares in Spider Technologies AB. Spider Technologies AB is...
Momentum Group’s Acquisition of Shares in Spider Technologies
Rain Therapeutics’ $125 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Rain Therapeutics Inc. (Rain), a clinical-stage company developing precision oncology therapeutics, executed its initial public offering...
Design Therapeutics’s $276 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Design Therapeutics, Inc. Design Therapeutics, Inc. executed its initial public...
Connect Biopharma’s $219.9 Million Initial Public Offering
Latham & Watkins LLP and Maples and Calder represented Connect Biopharma in the transaction. Global Law Office and Davis Polk advised joint book-running managers. Connect Biopharma...
SparkCognition’s Acquisition Of Nomura’s Interests In AIM²
Ashurst advised Nomura on the deal, while Latham & Watkins LLP, alongside Appleby, represented SparkCognition.Nomura sold its interest in AIM² to SparkCognition, a leading artificial intelligence (AI)...